Palo Santo Fund

Psylo is a drug development company that focuses on next-generation psychedelics.

Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.

Journey Clinical is a platform that provides services to member psychotherapy practices which are independently owned and operated.

Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines.

Developing novel therapeutics from the kanna plant

Fluence offers continuing education and certificate programs in psychedelic integration and psychedelic-assisted therapy.

Wavepaths creates accessible tools in psychedelic therapy intended for inner exploration and personal transformation.

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Journey Clinical is a platform that provides services to member psychotherapy practices which are independently owned and operated.